RYTM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $19,866,811.44

Rhythm Pharmaceuticals Insider Trading History Chart

Rhythm Pharmaceuticals Share Price & Price History

^$56.12

▲ +0.64 (1.15%)

As of 12/20/2024 06:51 PM ET

Days: 30 | 90 | 365

Is Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Click here now for the urgent details.

Rhythm Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/11/2024	Jennifer Kayden Lee	EVP	Sell	66,861	$66.33	$4,434,890.13	972
11/11/2024	Joseph Shulman	insider	Sell	13,281	$66.44	$882,389.64
11/7/2024	Pamela J. Cramer	Insider	Sell	4,688	$65.00	$304,720.00	13,500
9/17/2024	Jennifer L. Good	Director	Sell	31,751	$52.40	$1,663,752.40	3,000
9/10/2024	Lynn A. Tetrault	Director	Sell	17,501	$49.65	$868,924.65	3,000
9/9/2024	Pamela J. Cramer	Insider	Sell	4,099	$50.03	$205,072.97	13,500
8/26/2024	Lynn A. Tetrault	Director	Sell	4,300	$50.01	$215,043.00	3,000
8/26/2024	Pamela J. Cramer	Insider	Sell	3,200	$50.01	$160,032.00	13,500
8/9/2024	Pamela J. Cramer	Insider	Sell	49,006	$45.15	$2,212,620.90	13,500
7/29/2024	Pamela J. Cramer	Insider	Sell	1,395	$49.06	$68,438.70	31,735
7/16/2024	Joseph Shulman	Insider	Sell	10,468	$53.00	$554,804.00	30
7/12/2024	Joseph Shulman	Insider	Sell	5,313	$50.01	$265,703.13	30
5/9/2024	Joseph Shulman	Insider	Sell	3,984	$38.47	$153,264.48	30
4/2/2024	Christopher Paul German	CAO	Sell	368	$41.76	$15,367.68	795
3/21/2024	Joseph Shulman	Insider	Sell	18,235	$40.34	$735,599.90	30
3/19/2024	David P. Meeker	CEO	Sell	45,494	$39.22	$1,784,274.68	174,605
3/19/2024	Hunter C. Smith	CFO	Sell	15,515	$39.22	$608,498.30	97,939
3/19/2024	Yann Mazabraud	EVP	Sell	16,000	$39.22	$627,520.00	24,495
2/14/2024	Joseph Shulman	Insider	Sell	1,089	$50.01	$54,460.89	30
2/12/2024	Hunter C. Smith	CFO	Sell	1,209	$51.38	$62,118.42	80,413
2/12/2024	Joseph Shulman	Insider	Sell	791	$51.38	$40,641.58	3,457
2/12/2024	Yann Mazabraud	EVP	Sell	1,594	$51.38	$81,899.72	7,702
2/9/2024	Joseph Shulman	Insider	Sell	71,774	$50.38	$3,615,974.12	2,686
12/27/2023	Joseph Shulman	Insider	Sell	5,015	$50.01	$250,800.15	1,126
12/5/2023	Hunter C. Smith	CFO	Sell	7,026	$35.06	$246,331.56	61,406
11/24/2023	Hunter C. Smith	CFO	Sell	10,974	$35.02	$384,309.48	61,406
11/8/2023	Jennifer Kayden Lee	EVP	Sell	5,712	$28.90	$165,076.80	1,647
11/3/2023	Jennifer Kayden Lee	EVP	Sell	80	$28.00	$2,240.00	1,647
9/5/2023	Jennifer Kayden Lee	EVP	Sell	6,166	$28.05	$172,956.30	1,647
8/9/2023	Jennifer Kayden Lee	EVP	Sell	1,718	$24.66	$42,365.88	3,294
8/7/2023	Jennifer Kayden Lee	EVP	Sell	11,223	$24.18	$271,372.14	3,294
7/26/2023	Pamela J. Cramer	Insider	Sell	930	$17.64	$16,405.20	8,418
3/29/2023	William T Roberts	CAO	Sell	912	$17.50	$15,960.00	7,872
2/14/2023	Hunter C. Smith	CFO	Sell	702	$26.87	$18,862.74	59,406
2/14/2023	Jennifer Chien	EVP	Sell	635	$26.87	$17,062.45	4,940
2/14/2023	Joseph Shulman	Insider	Sell	554	$26.87	$14,885.98	3,741
2/9/2023	Hunter C. Smith	CFO	Sell	1,398	$27.66	$38,668.68	57,779
2/9/2023	Jennifer Chien	EVP	Sell	1,192	$27.66	$32,970.72	3,556
2/9/2023	Pamela J. Cramer	Insider	Sell	834	$27.66	$23,068.44	6,151
2/9/2023	William T Roberts	CAO	Sell	959	$27.66	$26,525.94	6,294
8/19/2022	Pamela J. Cramer	Insider	Sell	13,493	$24.83	$335,031.19	2,224
7/27/2022	Pamela J. Cramer	Insider	Sell	901	$11.68	$10,523.68	2,224
7/1/2022	Hunter C. Smith	CFO	Sell	7,547	$4.08	$30,791.76	57,614
3/29/2022	William T Roberts	CAO	Sell	1,023	$11.13	$11,385.99
2/15/2022	Hunter C. Smith	CFO	Sell	833	$6.10	$5,081.30
2/15/2022	Joseph Shulman	Insider	Sell	557	$6.10	$3,397.70
2/15/2022	Yann Mazabraud	EVP	Sell	934	$6.10	$5,697.40

Is Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

Click here now for the urgent details.

SEC Filings (Institutional Ownership Changes) for Rhythm Pharmaceuticals (NASDAQ:RYTM)

Institutional Buying and Selling by Quarter

Rhythm Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/19/2024	Principal Financial Group Inc.	32,586	$1.71M	0.0%	+241.9%	0.053%
11/27/2024	Franklin Resources Inc.	259,416	$13.03M	0.0%	+11.5%	0.422%
11/16/2024	Geode Capital Management LLC	1,256,188	$65.82M	0.0%	+0.3%	2.044%
11/15/2024	Frazier Life Sciences Management L.P.	2,416,952	$126.62M	5.1%	+1.9%	3.933%
11/15/2024	Barclays PLC	106,397	$5.57M	0.0%	+79.6%	0.173%
11/15/2024	National Bank of Canada FI	341,507	$17.89M	0.0%	-15.5%	0.556%
11/15/2024	Castleark Management LLC	19,260	$1.01M	0.0%	+1.3%	0.031%
11/15/2024	Wellington Management Group LLP	27,716	$1.45M	0.0%	-86.3%	0.045%
11/15/2024	State Street Corp	1,993,166	$104.42M	0.0%	-0.5%	3.243%
11/15/2024	Stifel Financial Corp	19,842	$1.04M	0.0%	-29.3%	0.032%
11/15/2024	Quantinno Capital Management LP	16,120	$0.85M	0.0%	-11.0%	0.026%
11/15/2024	Janus Henderson Group PLC	598,122	$31.34M	0.0%	+0.8%	0.973%
11/15/2024	HighVista Strategies LLC	37,426	$1.96M	0.7%	+160.6%	0.061%
11/15/2024	Checkpoint Capital L.P.	663,381	$34.76M	17.2%	-28.1%	1.079%
11/14/2024	Bellevue Group AG	15,700	$0.82M	0.0%	+20.8%	0.026%
11/14/2024	Alkeon Capital Management LLC	1,167,700	$61.18M	0.1%	+16.8%	1.900%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	225,373	$11.81M	0.0%	-4.7%	0.367%
11/14/2024	Healthcare of Ontario Pension Plan Trust Fund	1,111,043	$58.21M	0.1%	+14.9%	1.808%
11/13/2024	BNP Paribas Financial Markets	14,425	$0.76M	0.0%	+307.1%	0.023%
11/13/2024	FMR LLC	50,295	$2.64M	0.0%	+79.7%	0.082%
11/13/2024	The Manufacturers Life Insurance Company	48,703	$2.55M	0.0%	-1.2%	0.079%
11/13/2024	Loomis Sayles & Co. L P	636,628	$33.35M	0.0%	N/A	1.036%
11/12/2024	Penserra Capital Management LLC	25,063	$1.31M	0.0%	N/A	0.041%
11/12/2024	Algert Global LLC	54,171	$2.84M	0.1%	-48.0%	0.088%
11/12/2024	Charles Schwab Investment Management Inc.	433,866	$22.73M	0.0%	+1.4%	0.706%
11/9/2024	Primecap Management Co. CA	7,216,911	$378.09M	0.3%	-1.3%	11.806%
11/9/2024	Intech Investment Management LLC	12,386	$0.65M	0.0%	N/A	0.020%
11/7/2024	Quest Partners LLC	9,167	$0.48M	0.0%	+451.6%	0.015%
11/5/2024	Victory Capital Management Inc.	18,186	$0.95M	0.0%	+158.0%	0.030%
10/31/2024	Principal Financial Group Inc.	32,586	$1.71M	0.0%	+241.9%	0.053%
10/29/2024	Harbor Capital Advisors Inc.	41,368	$2.17M	0.1%	+19.5%	0.068%
10/25/2024	China Universal Asset Management Co. Ltd.	11,758	$0.62M	0.1%	+64.1%	0.019%
10/24/2024	Nisa Investment Advisors LLC	66,240	$3.47M	0.0%	-82.3%	0.109%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,211	$0.11M	0.0%	+21.5%	0.004%
10/23/2024	Assenagon Asset Management S.A.	20,052	$1.05M	0.0%	-91.3%	0.033%
10/23/2024	Hennion & Walsh Asset Management Inc.	100,961	$5.29M	0.2%	+4.8%	0.165%
10/11/2024	Creative Planning	8,594	$0.45M	0.0%	N/A	0.014%
10/11/2024	Wedge Capital Management L L P NC	48,844	$2.56M	0.0%	-22.7%	0.080%
10/11/2024	ORG Wealth Partners LLC	1,206	$63K	0.0%	N/A	0.002%
10/10/2024	Exchange Traded Concepts LLC	15,057	$0.79M	0.0%	+26.3%	0.025%
10/5/2024	Handelsbanken Fonder AB	19,321	$1.01M	0.0%	+21.4%	0.032%
10/3/2024	SG Americas Securities LLC	7,519	$0.39M	0.0%	-77.7%	0.012%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	967,243	$39.72M	0.1%	+32.4%	1.582%
8/27/2024	Clearbridge Investments LLC	88,108	$3.62M	0.0%	-2.1%	0.145%
8/16/2024	Perceptive Advisors LLC	3,446,579	$141.52M	3.4%	+5.4%	5.638%
8/16/2024	Algert Global LLC	104,132	$4.28M	0.1%	+50.8%	0.170%
8/16/2024	Frazier Life Sciences Management L.P.	2,371,304	$97.37M	4.6%	+8.3%	3.879%
8/16/2024	Driehaus Capital Management LLC	1,182,370	$48.55M	0.5%	+38.2%	1.934%
8/15/2024	The Manufacturers Life Insurance Company	49,291	$2.02M	0.0%	+3.5%	0.081%
8/15/2024	AQR Capital Management LLC	103,830	$4.26M	0.0%	+46.2%	0.170%
8/14/2024	Squarepoint Ops LLC	26,243	$1.08M	0.0%	-75.9%	0.043%
8/14/2024	Marshall Wace LLP	106,809	$4.39M	0.0%	+440.8%	0.175%
8/14/2024	ProShare Advisors LLC	10,916	$0.45M	0.0%	-20.9%	0.018%
8/14/2024	Profund Advisors LLC	13,975	$0.57M	0.0%	-59.2%	0.023%
8/13/2024	Sei Investments Co.	7,370	$0.30M	0.0%	-35.7%	0.012%
8/13/2024	Canada Pension Plan Investment Board	417,000	$17.12M	0.0%	-27.7%	0.684%
8/13/2024	Public Employees Retirement Association of Colorado	5,463	$0.22M	0.0%	-12.6%	0.009%
8/9/2024	Primecap Management Co. CA	7,312,391	$300.25M	0.2%	-5.6%	11.993%
8/8/2024	Federated Hermes Inc.	1,660,784	$68.19M	0.2%	0.0%	2.724%
8/8/2024	Rice Hall James & Associates LLC	93,081	$3.82M	0.2%	+3.7%	0.153%
8/6/2024	Quest Partners LLC	1,662	$68K	0.0%	+513.3%	0.003%
8/6/2024	Candriam S.C.A.	271,398	$11.14M	0.1%	N/A	0.445%
8/5/2024	Arizona State Retirement System	12,627	$0.52M	0.0%	-2.8%	0.021%
8/5/2024	Victory Capital Management Inc.	7,049	$0.29M	0.0%	-53.3%	0.012%
8/3/2024	National Bank of Canada FI	404,242	$17.25M	0.0%	+10.0%	0.663%
8/3/2024	TD Asset Management Inc	31,000	$1.27M	0.0%	+12.3%	0.051%
8/2/2024	JGP Global Gestao de Recursos Ltda.	5,814	$0.24M	0.3%	-94.5%	0.010%
8/1/2024	Rhumbline Advisers	83,063	$3.41M	0.0%	+8.3%	0.136%
7/29/2024	Principal Financial Group Inc.	9,532	$0.39M	0.0%	+32.8%	0.016%
7/26/2024	Bank of New York Mellon Corp	191,871	$7.88M	0.0%	+14.3%	0.315%
7/20/2024	Nisa Investment Advisors LLC	374,347	$15.37M	0.1%	+157.7%	0.614%
7/20/2024	Hennion & Walsh Asset Management Inc.	96,378	$3.96M	0.2%	+10.8%	0.158%
7/18/2024	Assenagon Asset Management S.A.	229,491	$9.42M	0.0%	-19.7%	0.376%
7/17/2024	Wedge Capital Management L L P NC	63,197	$2.60M	0.0%	-14.5%	0.104%
7/16/2024	ORG Partners LLC	1,206	$51K	0.0%	N/A	0.002%
7/12/2024	SG Americas Securities LLC	33,727	$1.39M	0.0%	+348.9%	0.055%
7/10/2024	CWM LLC	657	$27K	0.0%	+62.6%	0.001%
7/9/2024	Harbor Capital Advisors Inc.	34,627	$1.42M	0.1%	+52.0%	0.057%
5/29/2024	Opaleye Management Inc.	515,000	$22.32M	4.9%	-15.6%	0.845%
5/17/2024	Comerica Bank	33,118	$1.44M	0.0%	-2.7%	0.054%
5/17/2024	Castleark Management LLC	63,900	$2.77M	0.1%	N/A	0.105%
5/16/2024	California State Teachers Retirement System	47,894	$2.08M	0.0%	-2.3%	0.079%
5/16/2024	Janus Henderson Group PLC	621,427	$26.93M	0.0%	-0.1%	1.019%
5/16/2024	Bayesian Capital Management LP	15,355	$0.67M	0.1%	N/A	0.025%
5/15/2024	Public Employees Retirement Association of Colorado	6,249	$0.27M	0.0%	-9.6%	0.010%
5/15/2024	Bellevue Group AG	12,500	$0.54M	0.0%	-62.0%	0.021%
5/15/2024	Price T Rowe Associates Inc. MD	481,533	$20.87M	0.0%	-15.9%	0.790%
5/14/2024	Canada Pension Plan Investment Board	577,000	$25M	0.0%	+116.1%	0.946%
5/14/2024	Nan Fung Group Holdings Ltd	49,120	$2.13M	2.0%	+22.6%	0.081%
5/14/2024	Natixis	6,050	$0.26M	0.0%	-92.5%	0.010%
5/14/2024	Healthcare of Ontario Pension Plan Trust Fund	730,643	$31.66M	0.1%	+381.2%	1.198%
5/14/2024	American International Group Inc.	26,318	$1.14M	0.0%	+3.1%	0.043%
5/14/2024	National Bank of Canada FI	367,517	$15.93M	0.0%	+53.8%	0.603%
5/13/2024	Clearbridge Investments LLC	90,004	$3.90M	0.0%	-1.3%	0.148%
5/10/2024	Vanguard Group Inc.	3,304,146	$143.17M	0.0%	+2.4%	5.419%
5/9/2024	Lord Abbett & CO. LLC	281,157	$12.18M	0.0%	-0.8%	0.461%
5/8/2024	ProShare Advisors LLC	13,808	$0.60M	0.0%	+12.4%	0.023%
5/7/2024	Sei Investments Co.	11,470	$0.50M	0.0%	+85.8%	0.019%
5/7/2024	Swiss National Bank	93,300	$4.04M	0.0%	+4.0%	0.153%
5/1/2024	Capstone Investment Advisors LLC	6,738	$0.29M	0.0%	N/A	0.011%

Data available starting January 2016

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $56.12

$55.47

$58.16

50 Day Range

MA: $56.39

$47.73

$67.33

52 Week Range

Now: $56.12

$35.17

$68.58

Volume

1,520,023 shs

Average Volume

548,620 shs

Market Capitalization

$3.45 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.14

Who are the company insiders with the largest holdings of Rhythm Pharmaceuticals?: Rhythm Pharmaceuticals' top insider shareholders include:
David P Meeker (CEO)
Hunter C Smith (CFO)
Pamela J Cramer (Insider)
Yann Mazabraud (EVP)
William T Roberts (CAO)
Jennifer Chien (EVP)
Joseph Shulman (Insider)
Jennifer Kayden Lee (EVP)
Jennifer L Good (Director)
Lynn A Tetrault (Director)
Christopher Paul German (CAO)
Learn More about top insider investors at Rhythm Pharmaceuticals.
Who are the major institutional investors of Rhythm Pharmaceuticals?: Rhythm Pharmaceuticals' top institutional shareholders include:
Primecap Management Co. CA — 11.81%
Frazier Life Sciences Management L.P. — 3.93%
State Street Corp — 3.24%
Geode Capital Management LLC — 2.04%
Alkeon Capital Management LLC — 1.90%
Healthcare of Ontario Pension Plan Trust Fund — 1.81%
Learn More about top institutional investors of Rhythm Pharmaceuticals stock.
Which institutional investors are selling Rhythm Pharmaceuticals stock?: Within the last quarter, RYTM stock was sold by these institutional investors:
Nisa Investment Advisors LLC
Checkpoint Capital L.P.
Assenagon Asset Management S.A.
Wellington Management Group LLP
Primecap Management Co. CA
National Bank of Canada FI
Algert Global LLC
SG Americas Securities LLC
Within the last year, company insiders that have sold Rhythm Pharmaceuticals company stock include:
David P Meeker (CEO)
Hunter C Smith (CFO)
Pamela J Cramer (Insider)
Yann Mazabraud (EVP)
William T Roberts (CAO)
Jennifer Chien (EVP)
Joseph Shulman (Insider)
Jennifer Kayden Lee (EVP)
Jennifer L Good (Director)
Learn More investors selling Rhythm Pharmaceuticals stock.
Which institutional investors are buying Rhythm Pharmaceuticals stock?: In the last quarter, RYTM stock was acquired by institutional investors including:
Loomis Sayles & Co. L P
Alkeon Capital Management LLC
Healthcare of Ontario Pension Plan Trust Fund
Barclays PLC
Frazier Life Sciences Management L.P.
Franklin Resources Inc.
Penserra Capital Management LLC
HighVista Strategies LLC